bh3 mimetics (Mimetics)
86
Structured Review
Mimetics
bh3 mimetics
Bh3 Mimetics, supplied by Mimetics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bh3-mimetics/bh3+mimetics/pm42201388-430-3-4
Average 86 stars, based on 1 article reviews
Bh3 Mimetics, supplied by Mimetics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bh3-mimetics/bh3+mimetics/pm42201388-430-3-4
Average 86 stars, based on 1 article reviews
bh3 mimetics - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
Binding Assay:Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: In consequence TCA cycle is strongly downregulated that sensitive Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: Major comments: *Figure 1G: The authors indicate that Article Title: Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia Article Snippet: Alternative inhibitors of BTK, Article Title: Article Snippet: Table of Contents Appendix Figure S1: Enhanced apoptosis induction by the combination treatment of Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: No signal was detected when Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs. Article Snippet: Ewald, L.; Dittmann, J.; Vogler, M.; Fulda, Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Moreover, identifying the specific Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Enzyme-linked Immunosorbent Assay:Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: In consequence TCA cycle is strongly downregulated that sensitive Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: Major comments: *Figure 1G: The authors indicate that Article Title: Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia Article Snippet: Alternative inhibitors of BTK, Article Title: Article Snippet: Table of Contents Appendix Figure S1: Enhanced apoptosis induction by the combination treatment of Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: No signal was detected when Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs. Article Snippet: Ewald, L.; Dittmann, J.; Vogler, M.; Fulda, Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Moreover, identifying the specific Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Clone Assay:Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: In consequence TCA cycle is strongly downregulated that sensitive Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: Major comments: *Figure 1G: The authors indicate that Article Title: Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia Article Snippet: Alternative inhibitors of BTK, Article Title: Article Snippet: Table of Contents Appendix Figure S1: Enhanced apoptosis induction by the combination treatment of Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: No signal was detected when Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs. Article Snippet: Ewald, L.; Dittmann, J.; Vogler, M.; Fulda, Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Moreover, identifying the specific Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Concentration Assay:Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: In consequence TCA cycle is strongly downregulated that sensitive Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: Major comments: *Figure 1G: The authors indicate that Article Title: Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia Article Snippet: Alternative inhibitors of BTK, Article Title: Article Snippet: Table of Contents Appendix Figure S1: Enhanced apoptosis induction by the combination treatment of Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: No signal was detected when Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs. Article Snippet: Ewald, L.; Dittmann, J.; Vogler, M.; Fulda, Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Moreover, identifying the specific Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Incubation:Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: In consequence TCA cycle is strongly downregulated that sensitive Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: Major comments: *Figure 1G: The authors indicate that Article Title: Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia Article Snippet: Alternative inhibitors of BTK, Article Title: Article Snippet: Table of Contents Appendix Figure S1: Enhanced apoptosis induction by the combination treatment of Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: No signal was detected when Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs. Article Snippet: Ewald, L.; Dittmann, J.; Vogler, M.; Fulda, Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Moreover, identifying the specific Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Flow Cytometry:Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: In consequence TCA cycle is strongly downregulated that sensitive Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: Major comments: *Figure 1G: The authors indicate that Article Title: Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia Article Snippet: Alternative inhibitors of BTK, Article Title: Article Snippet: Table of Contents Appendix Figure S1: Enhanced apoptosis induction by the combination treatment of Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: No signal was detected when Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs. Article Snippet: Ewald, L.; Dittmann, J.; Vogler, M.; Fulda, Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Moreover, identifying the specific Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Standard Deviation:Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: In consequence TCA cycle is strongly downregulated that sensitive Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: Major comments: *Figure 1G: The authors indicate that Article Title: Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia Article Snippet: Alternative inhibitors of BTK, Article Title: Article Snippet: Table of Contents Appendix Figure S1: Enhanced apoptosis induction by the combination treatment of Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: No signal was detected when Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs. Article Snippet: Ewald, L.; Dittmann, J.; Vogler, M.; Fulda, Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Moreover, identifying the specific Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Disruption:Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: In consequence TCA cycle is strongly downregulated that sensitive Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: Major comments: *Figure 1G: The authors indicate that Article Title: Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia Article Snippet: Alternative inhibitors of BTK, Article Title: Article Snippet: Table of Contents Appendix Figure S1: Enhanced apoptosis induction by the combination treatment of Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: No signal was detected when Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs. Article Snippet: Ewald, L.; Dittmann, J.; Vogler, M.; Fulda, Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Moreover, identifying the specific Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Staining:Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: In consequence TCA cycle is strongly downregulated that sensitive Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: Major comments: *Figure 1G: The authors indicate that Article Title: Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia Article Snippet: Alternative inhibitors of BTK, Article Title: Article Snippet: Table of Contents Appendix Figure S1: Enhanced apoptosis induction by the combination treatment of Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: No signal was detected when Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs. Article Snippet: Ewald, L.; Dittmann, J.; Vogler, M.; Fulda, Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Moreover, identifying the specific Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Imaging:Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: In consequence TCA cycle is strongly downregulated that sensitive Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: Major comments: *Figure 1G: The authors indicate that Article Title: Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia Article Snippet: Alternative inhibitors of BTK, Article Title: Article Snippet: Table of Contents Appendix Figure S1: Enhanced apoptosis induction by the combination treatment of Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: No signal was detected when Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs. Article Snippet: Ewald, L.; Dittmann, J.; Vogler, M.; Fulda, Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Moreover, identifying the specific Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Immunofluorescence:Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: In consequence TCA cycle is strongly downregulated that sensitive Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: Major comments: *Figure 1G: The authors indicate that Article Title: Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia Article Snippet: Alternative inhibitors of BTK, Article Title: Article Snippet: Table of Contents Appendix Figure S1: Enhanced apoptosis induction by the combination treatment of Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: No signal was detected when Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs. Article Snippet: Ewald, L.; Dittmann, J.; Vogler, M.; Fulda, Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Moreover, identifying the specific Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: CRISPR:Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: In consequence TCA cycle is strongly downregulated that sensitive Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: Major comments: *Figure 1G: The authors indicate that Article Title: Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia Article Snippet: Alternative inhibitors of BTK, Article Title: Article Snippet: Table of Contents Appendix Figure S1: Enhanced apoptosis induction by the combination treatment of Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: No signal was detected when Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs. Article Snippet: Ewald, L.; Dittmann, J.; Vogler, M.; Fulda, Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Moreover, identifying the specific Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Knock-Out:Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: In consequence TCA cycle is strongly downregulated that sensitive Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: Major comments: *Figure 1G: The authors indicate that Article Title: Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia Article Snippet: Alternative inhibitors of BTK, Article Title: Article Snippet: Table of Contents Appendix Figure S1: Enhanced apoptosis induction by the combination treatment of Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: No signal was detected when Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs. Article Snippet: Ewald, L.; Dittmann, J.; Vogler, M.; Fulda, Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Moreover, identifying the specific Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Sequencing:Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: In consequence TCA cycle is strongly downregulated that sensitive Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: Major comments: *Figure 1G: The authors indicate that Article Title: Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia Article Snippet: Alternative inhibitors of BTK, Article Title: Article Snippet: Table of Contents Appendix Figure S1: Enhanced apoptosis induction by the combination treatment of Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: No signal was detected when Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs. Article Snippet: Ewald, L.; Dittmann, J.; Vogler, M.; Fulda, Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Moreover, identifying the specific Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Western Blot:Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: In consequence TCA cycle is strongly downregulated that sensitive Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: Major comments: *Figure 1G: The authors indicate that Article Title: Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia Article Snippet: Alternative inhibitors of BTK, Article Title: Article Snippet: Table of Contents Appendix Figure S1: Enhanced apoptosis induction by the combination treatment of Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: No signal was detected when Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs. Article Snippet: Ewald, L.; Dittmann, J.; Vogler, M.; Fulda, Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Moreover, identifying the specific Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Two Tailed Test:Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: In consequence TCA cycle is strongly downregulated that sensitive Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: Major comments: *Figure 1G: The authors indicate that Article Title: Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia Article Snippet: Alternative inhibitors of BTK, Article Title: Article Snippet: Table of Contents Appendix Figure S1: Enhanced apoptosis induction by the combination treatment of Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: No signal was detected when Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs. Article Snippet: Ewald, L.; Dittmann, J.; Vogler, M.; Fulda, Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Moreover, identifying the specific Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Purification:Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: In consequence TCA cycle is strongly downregulated that sensitive Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: Major comments: *Figure 1G: The authors indicate that Article Title: Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia Article Snippet: Alternative inhibitors of BTK, Article Title: Article Snippet: Table of Contents Appendix Figure S1: Enhanced apoptosis induction by the combination treatment of Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: No signal was detected when Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs. Article Snippet: Ewald, L.; Dittmann, J.; Vogler, M.; Fulda, Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Moreover, identifying the specific Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Expressing:Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: In consequence TCA cycle is strongly downregulated that sensitive Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: Major comments: *Figure 1G: The authors indicate that Article Title: Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia Article Snippet: Alternative inhibitors of BTK, Article Title: Article Snippet: Table of Contents Appendix Figure S1: Enhanced apoptosis induction by the combination treatment of Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: No signal was detected when Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs. Article Snippet: Ewald, L.; Dittmann, J.; Vogler, M.; Fulda, Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Moreover, identifying the specific Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Software:Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: In consequence TCA cycle is strongly downregulated that sensitive Article Title: Activation of LXRβ Inhibits Tumor Respiration and is Synthetically Lethal with Bcl-xL Inhibition Article Snippet: Major comments: *Figure 1G: The authors indicate that Article Title: Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia Article Snippet: Alternative inhibitors of BTK, Article Title: Article Snippet: Table of Contents Appendix Figure S1: Enhanced apoptosis induction by the combination treatment of Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: No signal was detected when Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs. Article Snippet: Ewald, L.; Dittmann, J.; Vogler, M.; Fulda, Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: Moreover, identifying the specific Article Title: Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Article Snippet: |
